SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-163542
Filing Date
2023-06-08
Accepted
2023-06-08 16:29:01
Documents
12
Period of Report
2023-06-07
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d519560d8k.htm   iXBRL 8-K 38590
  Complete submission text file 0001193125-23-163542.txt   161566

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cere-20230607.xsd EX-101.SCH 2877
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE cere-20230607_lab.xml EX-101.LAB 17994
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cere-20230607_pre.xml EX-101.PRE 11279
6 EXTRACTED XBRL INSTANCE DOCUMENT d519560d8k_htm.xml XML 3362
Mailing Address 222 JACOBS STREET SUITE 200 CAMBRIDGE MA 02141
Business Address 222 JACOBS STREET SUITE 200 CAMBRIDGE MA 02141 844-304-2048
Cerevel Therapeutics Holdings, Inc. (Filer) CIK: 0001805387 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39311 | Film No.: 231002291
SIC: 2834 Pharmaceutical Preparations